% | $
Quotes you view appear here for quick access.

Immune Pharmaceuticals, Inc. Message Board

  • jonaustin1481 jonaustin1481 Jun 22, 2009 4:35 PM Flag


    In my opinion, it would not be wise to hold more than a token position in EPCT, especially now.

    One has to balance the risks with the potential rewards and at this particular point in time, that ratio does not look favorable.

    On the one hand, we may be on the precipice of the overall market turning downward AND another dilution in short order.

    Balance that set of conditions with the possibility of a partner agreement, which has the following caveats:

    1 - The likelihood of that agreement being announced BEFORE the share increase is remote.

    2 - Given the delays and obfuscation by management, any agreement, should one be executed, will not likely be earth-shattering, IE - mediocre terms, at best.

    On the whole, the picture is not advantageous for holding any significant number of shares.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
0.356+0.007(+1.98%)Aug 26 3:59 PMEDT